Context Therapeutics Inc.
CNTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $62 | $58 | $61 |
| - Cash | $77 | $84 | $89 | $94 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | -$21 | -$31 | -$33 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$10 | -$6 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$10 | -$9 | -$5 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.093 | -0.05 | -0.057 |
| % Growth | -7.9% | -85.4% | 12.6% | – |
| Operating Cash Flow | -$7 | -$6 | -$5 | -$5 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$7 | -$6 | -$5 | -$5 |